Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,736,232 papers from all fields of science
Search
Sign In
Create Free Account
ABT-089
Known as:
A-87089.0
, ABT 089
, ABYT 089
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
pozanicline
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.
M. Quik
,
Danhui Zhang
,
X. Perez
,
T. Bordia
Pharmacology & therapeutics
2014
Corpus ID: 31826605
2014
2014
ABT‐089 and ABT‐894 reduce levodopa‐induced dyskinesias in a monkey model of Parkinson's disease
Danhui Zhang
,
T. Bordia
,
M. McGregor
,
J. McIntosh
,
M. Decker
,
M. Quik
Movement disorders : official journal of the…
2014
Corpus ID: 23782278
Levodopa‐induced dyskinesias (LIDs) are a serious complication of levodopa therapy for Parkinson's disease for which there is…
Expand
2009
2009
Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination.
David J. Anderson
,
J. Malysz
,
+5 authors
M. Gopalakrishnan
Biochemical pharmacology
2009
Corpus ID: 205962751
Highly Cited
2008
Highly Cited
2008
Glutamatergic Contributions to Nicotinic Acetylcholine Receptor Agonist-Evoked Cholinergic Transients in the Prefrontal Cortex
V. Parikh
,
K. Man
,
M. Decker
,
M. Sarter
The Journal of Neuroscience
2008
Corpus ID: 17409952
Because modulation of cortical cholinergic neurotransmission has been hypothesized to represent a necessary mechanism mediating…
Expand
Review
2007
Review
2007
Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition.
T. Wilens
,
M. Decker
Biochemical pharmacology
2007
Corpus ID: 29808856
Review
2004
Review
2004
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders.
L. Rueter
,
David J. Anderson
,
+15 authors
J. Sullivan
CNS drug reviews
2004
Corpus ID: 33404958
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride salt] is a selective neuronal nicotinic receptor (NNR…
Expand
Highly Cited
1998
Highly Cited
1998
Central nicotinic receptor agonists ABT-418, ABT-089, and (–)-nicotine reduce distractibility in adult monkeys
M. Prendergast
,
W. J. Jackson
,
A. Terry Jr.
,
M. Decker
,
S. Arneric
,
J. Buccafusco
Psychopharmacology
1998
Corpus ID: 20080069
Abstract Increased distractibility is associated with both Alzheimer’s disease and attention deficit disorder. The present study…
Expand
Highly Cited
1998
Highly Cited
1998
Activation and inhibition of the human α7 nicotinic acetylcholine receptor by agonists
C. Briggs
,
D. Mckenna
Neuropharmacology
1998
Corpus ID: 45834866
Highly Cited
1997
Highly Cited
1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys.
M. Decker
,
A. Bannon
,
+10 authors
S. Arneric
The Journal of pharmacology and experimental…
1997
Corpus ID: 9441040
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride], a novel ligand at neuronal nicotinic acetylcholine…
Expand
Highly Cited
1997
Highly Cited
1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective properties.
J. Sullivan
,
D. Donnelly-roberts
,
+15 authors
S. Arneric
The Journal of pharmacology and experimental…
1997
Corpus ID: 11790586
Accumulating preclinical and clinical evidence data suggests that compounds that selectively activate neuronal nicotinic…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE